Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
Meningiomas are the most common primary intracranial tumors. The majority of
meningiomas are benign, but they can present different grades of dedifferentiation from …
meningiomas are benign, but they can present different grades of dedifferentiation from …
Neurofibromatosis type 2
Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that
results from mutations in the NF2 tumour suppressor gene located on chromosome 22q. It …
results from mutations in the NF2 tumour suppressor gene located on chromosome 22q. It …
Birth incidence and prevalence of tumor‐prone syndromes: estimates from a UK family genetic register service
DG Evans, E Howard, C Giblin, T Clancy… - American journal of …, 2010 - Wiley Online Library
Dominantly inherited tumor-prone syndromes are a significant health burden, but disease-
related morbidity can be reduced and life expectancy increased by a GR type approach …
related morbidity can be reduced and life expectancy increased by a GR type approach …
Neurofibromatosis: a review of NF1, NF2, and schwannomatosis
JL Kresak, M Walsh - Journal of pediatric genetics, 2016 - thieme-connect.com
The neurofibromatoses are a heterogeneous group of hereditary cancer syndromes that
lead to tumors of the central and peripheral nervous systems, as well as other organ …
lead to tumors of the central and peripheral nervous systems, as well as other organ …
Neurofibromatosis type 2 (NF2): a clinical and molecular review
DGR Evans - Orphanet journal of rare diseases, 2009 - Springer
Abstract Neurofibromatosis type 2 (NF2) is a tumour-prone disorder characterised by the
development of multiple schwannomas and meningiomas. Prevalence (initially estimated at …
development of multiple schwannomas and meningiomas. Prevalence (initially estimated at …
An update on the CNS manifestations of neurofibromatosis type 2
Neurofibromatosis type II (NF2) is a tumor predisposition syndrome characterized by the
development of distinctive nervous system lesions. NF2 results from loss-of-function …
development of distinctive nervous system lesions. NF2 results from loss-of-function …
Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought
Objective: To determine the incidence of vestibular schwannoma (VS) in sporadic,
neurofibromatosis type 2 (NF2) germ-line and mosaic form in a 10-year period. Study …
neurofibromatosis type 2 (NF2) germ-line and mosaic form in a 10-year period. Study …
Diagnostic criteria for schwannomatosis
The neurofibromatoses are a diverse group of genetic conditions that share a predisposition
to the development of tumors of the nerve sheath. Schwannomatosis is a recently …
to the development of tumors of the nerve sheath. Schwannomatosis is a recently …
Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis
Abstract Neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and
schwannomatosis (SWN) are three clinically distinct tumor predisposition syndromes with a …
schwannomatosis (SWN) are three clinically distinct tumor predisposition syndromes with a …
An update on the diagnosis and treatment of vestibular schwannoma
J Halliday, SA Rutherford, MG McCabe… - Expert review of …, 2018 - Taylor & Francis
Introduction: Vestibular schwannomas (VS) account for approximately 85% of tumors in the
cerebello-pontine angle, with a lifetime incidence of approximately 1 in 1000. Most are …
cerebello-pontine angle, with a lifetime incidence of approximately 1 in 1000. Most are …